Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Ultragenyx Pharmaceutical (RARE) Shares Issued (2016 - 2024)

Historic Shares Issued for Ultragenyx Pharmaceutical (RARE) over the last 8 years, with Q2 2024 value amounting to $381.0 million.

  • Ultragenyx Pharmaceutical's Shares Issued changed N/A to $381.0 million in Q2 2024 from the same period last year, while for Jun 2024 it was $390.1 million, marking a year-over-year change of. This contributed to the annual value of $11.3 million for FY2024, which is 3378.49% up from last year.
  • According to the latest figures from Q2 2024, Ultragenyx Pharmaceutical's Shares Issued is $381.0 million.
  • In the past 5 years, Ultragenyx Pharmaceutical's Shares Issued ranged from a high of $381.0 million in Q2 2024 and a low of $380000.0 during Q1 2020
  • For the 4-year period, Ultragenyx Pharmaceutical's Shares Issued averaged around $45.3 million, with its median value being $9.8 million (2021).
  • Its Shares Issued has fluctuated over the past 5 years, first crashed by 9988.5% in 2020, then skyrocketed by 325815.79% in 2021.
  • Quarter analysis of 4 years shows Ultragenyx Pharmaceutical's Shares Issued stood at $79.8 million in 2020, then tumbled by 91.32% to $6.9 million in 2021, then tumbled by 71.1% to $2.0 million in 2022, then surged by 18940.48% to $381.0 million in 2024.
  • Its Shares Issued stands at $381.0 million for Q2 2024, versus $2.0 million for Q4 2022 and $1.1 million for Q3 2022.